Aroa Biosurgery Ltd (ARX) Stock Statistics & Valuation Metrics

Aroa Biosurgery Ltd has a market cap or net worth of AUD 190.25M. The enterprise value is AUD 196.49M.

Market Cap

AUD 190.25M

Enterprise Value

AUD 196.49M

Aroa Biosurgery Ltd has 345,902,650 shares outstanding. The number of shares has decreased by -2.65% in one year.

Shares Outstanding

345,902,650

Owned by Insiders

0.24%

Owned by Institutions

0.05%

Aroa Biosurgery Ltd’s return on equity (ROE) is 0.05 and return on invested capital (ROIC) is 4.94%.

Return on Equity (ROE)

0.05

Return on Assets (ROA)

0.04

Return on Invested Capital (ROIC)

4.94%

Return on Capital Employed (ROCE)

0.05

Revenue Per Employee

338.04K

Profits Per Employee

15.23K

Employee Count

273

Asset Turnover

0.92

Inventory Turnover

2.52

The current PE Ratio of Aroa Biosurgery Ltd is 45.83. Aroa Biosurgery Ltd’s PEG ratio is 0.07.

PE Ratio

45.83

PS Ratio

1.38

PB Ratio

2.29

Price to FCF

15.43

Price to Operating Cash Flow

13.79

PEG Ratio

0.07

In the last 12 months, Aroa Biosurgery Ltd had revenue of 92.28M and earned 4.16M in profits. Earnings per share was 0.01.

Revenue

92.28M

Gross Profit

79.63M

Operating Income

4.36M

Pretax Income

3.85M

Net Income

4.16M

EBITDA

9.03M

Earnings Per Share (EPS)

0.01

In the last 12 months, operating cash flow was 13.76M and capital expenditures -1.45M, giving a free cash flow of 12.31M billion.

Operating Cash Flow

13.76M

Free Cash Flow

12.31M

Free Cash Flow per Share

0.04

Aroa Biosurgery Ltd pays an annual dividend of ―, resulting in a dividend yield of ―

Dividend Per Share

―

Dividend Yield

―

Payout Ratio

N/A

Free Cash Flow Yield

6.48%

Earnings Yield

2.19%

Beta

0.64

52-Week Price Change

-28.10%

50-Day Moving Average

0.53

200-Day Moving Average

0.59

Relative Strength Index (RSI)

58.84

Average Volume (3m)

261.40K

Aroa Biosurgery Ltd upcoming earnings date is Nov 26, 2026, TBA (Not Confirmed).

Last Earnings Date

May 25, 2026

Next Earnings Date

Nov 26, 2026

Ex-Dividend Date

―

Aroa Biosurgery Ltd as a current ratio of 4.77, with Debt / Equity ratio of 6.42%

Current Ratio

4.77

Quick Ratio

4.40

Debt to Market Cap

0.01

Net Debt to EBITDA

-1.35

Interest Coverage Ratio

10.37

In the past 12 months, Aroa Biosurgery Ltd has paid -310.12K in taxes.

Income Tax

-310.12K

Effective Tax Rate

-0.08

Aroa Biosurgery Ltd EV to EBITDA ratio is 12.28, with an EV/FCF ratio of 14.44.

EV to Sales

1.29

EV to EBITDA

12.28

EV to Free Cash Flow

14.44

EV to Operating Cash Flow

12.92

Aroa Biosurgery Ltd has AUD 22.60M in cash and marketable securities with AUD 5.31M in debt, giving a net cash position of AUD 17.29M billion.

Cash & Marketable Securities

AUD 22.60M

Total Debt

AUD 5.31M

Net Cash

AUD 17.29M

Net Cash Per Share

AUD 0.05

Tangible Book Value Per Share

AUD 0.19

Gross margin is 57.65%, with operating margin of 4.73%, and net profit margin of 3.01%.

Gross Margin

57.65%

Operating Margin

4.73%

Pretax Margin

4.87%

Net Profit Margin

3.01%

EBITDA Margin

10.48%

EBIT Margin

5.40%

The average price target for Aroa Biosurgery Ltd is AUD 0.94, which is 11.43% higher than the current price. The consensus rating is Moderate Buy

Price Target

AUD 0.94

Price Target Upside

70.91% Upside

Analyst Consensus

Moderate Buy

Analyst Count

2

Revenue Growth Forecast

19.23%

EPS Growth Forecast

―

Smart Score

5

AI Score

62